Inhaled corticosteroids (ICs) are the most effective anti-inflammatory agents available for the treatment of asthma. Since proper inhalation technique can significantly affect the amount of ICs delivered via metered-dose inhaler (MDI) or dry powder inhaler to the airways, patient education is essential. Large-volume spacer devices used with MDIs may double the efficacy of ICs by enhancing lung deposition, possibly reducing dosage and cost of therapy. At currently recommended dosages, ICs have an excellent safety profile and should be considered the mainstay of asthma therapy.
|Number of pages
|Journal of Respiratory Diseases
|Published - Jan 1 2001